Form SC 13G/A Jounce Therapeutics, Filed by: Cowen Financial Products LLC Feb 2, 2024 12:28PM
Jounce Therapeutics (JNCE) and Redx Pharma Terminate Proposed Merger Apr 3, 2023 05:17AM
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc Apr 3, 2023 02:00AM
Jounce Therapeutics (JNCE) to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights Mar 27, 2023 09:01AM
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights Mar 27, 2023 09:00AM


Mar 15, 2023 07:51AM Jounce Therapeutics (JNCE) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Mar 14, 2023 09:00PM Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Feb 23, 2023 05:46AM Jounce Therapeutics (JNCE) and Redx Announce Recommended Business Combination
Feb 23, 2023 02:30AM Redx and Jounce Announce Recommended Business Combination
Jan 23, 2023 03:48PM Form SC 13G/A Jounce Therapeutics, Filed by: Cowen Financial Products LLC
May 17, 2022 08:00AM Jounce Therapeutics to Present at Upcoming Investor Conferences
Apr 22, 2022 10:54AM Form SC 13G Jounce Therapeutics, Filed by: Cowen Financial Products LLC
Feb 28, 2022 08:00AM Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care Conference
Feb 4, 2022 05:31AM UPDATE: Cowen Upgrades Jounce Therapeutics (JNCE) to Outperform
Nov 9, 2021 08:00AM Jounce Therapeutics to Present at Upcoming Investor Conferences in November
Mar 12, 2021 11:10AM Jounce Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
Mar 10, 2021 05:46AM Jounce Therapeutics (JNCE) Prices 5M Share Common Offering at $11.25/Sh
Mar 9, 2021 10:17PM Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock
Mar 9, 2021 04:01PM Jounce Therapeutics (JNCE) to Offer Common Stock
Mar 9, 2021 04:01PM Jounce Therapeutics Announces Proposed Offering of Common Stock
Feb 23, 2021 08:00AM Jounce Therapeutics to Present at Upcoming Investor Conferences in March
Nov 9, 2020 08:00AM Jounce Therapeutics to Participate in a Virtual Fireside Chat at Cowen 2020 IO Next Summit
Feb 26, 2020 08:00AM Jounce Therapeutics to Present at Upcoming Investor Conferences in March
Mar 4, 2019 08:00AM Jounce Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference
Jun 5, 2018 05:42AM Cowen Downgrades Jounce Therapeutics (JNCE) to Market Perform
Mar 5, 2018 08:00AM Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
Apr 21, 2017 07:04AM Jounce Therapeutics (JNCE): Two New Catalysts - Cowen
Feb 28, 2017 08:00AM Jounce Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference
Feb 21, 2017 06:41AM Cowen Starts Jounce Therapeutics (JNCE) at Outperform
Jan 27, 2017 10:59AM Jounce Therapeutics (JNCE) IPO Opens up 13%
Dec 30, 2016 10:57AM Jounce Therapeutics Files $75M IPO, Plans to List on NASDAQ Under the Symbol 'JNCE'